As the U.S. stock market experiences mixed performance, with key indices such as the Dow Jones showing gains while the S&P 500 and Nasdaq face slight declines, investors are closely evaluating economic indicators and policy announcements for their potential impact on market stability. In this environment of uncertainty, identifying stocks that are undervalued relative to their intrinsic estimates can offer potential opportunities for investors seeking to navigate these turbulent conditions effectively.

Top 10 Undervalued Stocks Based On Cash Flows In The United States

Click here to see the full list of 182 stocks from our Undervalued US Stocks Based On Cash Flows screener.

We'll examine a selection from our screener results.

American Healthcare REIT

Overview: American Healthcare REIT, Inc. is a self-managed real estate investment trust specializing in the acquisition, ownership, and operation of a diverse range of clinical healthcare properties such as outpatient medical buildings and senior housing, with a market cap of approximately $4.50 billion.

Operations: The company's revenue segments consist of $137.72 million from outpatient medical buildings, $238.76 million from senior housing operating properties, $52.51 million from triple-net leased properties, and $1.58 billion from integrated senior health campuses.

Estimated Discount To Fair Value: 12.7%

American Healthcare REIT is trading at US$29.72, 12.7% below its estimated fair value of US$34.04, indicating potential undervaluation based on cash flows. Despite a forecasted revenue growth of 9.2% annually and expected profitability in three years, its dividend yield of 3.36% is not well covered by free cash flows. Earnings are projected to grow at an impressive rate of 38.67% per year, although return on equity remains low at a forecasted 3.6%.

• In light of our recent growth report, it seems possible that American Healthcare REIT's financial performance will exceed current levels.
• Navigate through the intricacies of American Healthcare REIT with our comprehensive financial health report here.

Equifax

Overview: Equifax Inc. is a data, analytics, and technology company with a market cap of $30.43 billion.

Operations: The company's revenue is primarily generated from three segments: International ($1.35 billion), Workforce Solutions ($2.43 billion), and U.S. Information Solutions ($1.89 billion).

Estimated Discount To Fair Value: 33.7%

Equifax, trading at US$243.62, is significantly undervalued with a fair value estimate of US$367.23, offering potential based on cash flows. The company reported strong earnings growth and forecasts annual profit increases of 21.9%, outpacing the broader market's 14.2%. Although revenue growth is projected at a slower 8.9% annually, Equifax's strategic focus on bolt-on acquisitions and consistent dividend payments underscore its commitment to shareholder returns despite high debt levels.

• The analysis detailed in our Equifax growth report hints at robust future financial performance.
• Get an in-depth perspective on Equifax's balance sheet by reading our health report here.

Workiva

Overview: Workiva Inc. offers cloud-based reporting solutions globally and has a market capitalization of approximately $4.69 billion.

Operations: Revenue Segments (in millions of $): null

Estimated Discount To Fair Value: 47.4%

Workiva, priced at US$89.32, is considerably undervalued with a fair value estimate of US$169.66. The company reported revenue growth to US$738.68 million in 2024 from US$630.04 million the previous year, while reducing its net loss to US$55.04 million from US$127.53 million. With expected revenue growth of 14.6% per year and profitability anticipated within three years, Workiva's cash flow potential remains robust despite current negative equity and forecasted losses for 2025.

• The growth report we've compiled suggests that Workiva's future prospects could be on the up.
• Click here and access our complete balance sheet health report to understand the dynamics of Workiva.

Where To Now?

• Gain an insight into the universe of 182 Undervalued US Stocks Based On Cash Flows by clicking here.
• Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
• Maximize your investment potential with Simply Wall St, the comprehensive app that offers global market insights for free.

Ready For A Different Approach?

• Explore high-performing small cap companies that haven't yet garnered significant analyst attention.
• Diversify your portfolio with solid dividend payers offering reliable income streams to weather potential market turbulence.
• Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include NYSE:AHR NYSE:EFX and NYSE:WK.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com